Cooper Companies Inc

US

COO

Health Care

90.04 ₽

Current price

Sell
90.04 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    176 / 236

  • Position in country

    10304 / 14179

  • Return on Assets, %

    2.4

    1.6

  • Net income margin, %

    8.7

    2.7

  • EBITDA margin, %

    26.8

    10.2

  • Debt to Equity, %

    36

    13.9

  • Intangible assets and goodwill, %

    46.7

    2.7

  • Revenue CAGR 3Y, %

    13.9

    11.3

  • Total Equity change 1Y, %

    4.9

    -0.3

  • Revenue Y, % chg

    8.4

    0

  • P/E

    94.5

    25.8

  • P/BV

    2.4

    1.5

  • P/S

    5

    2.8

  • EV/S

    5.7

    2.5

  • EV/EBITDA

    22.1

    9

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    17.6

    36.5

  • Forward P/E

    25.1

    18.3

  • Forward Dividend Yield, %

    0

    0.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0.5

    32.2

Get an analytical review of this company

Competitors

Ranks

  • Lantheus Holdings Inc

    00%

  • Rxsight Inc

    00%

  • Merit Medical Systems Inc

    00%

  • STAAR Surgical Co

    00%

  • Align Technology Inc

    00%

  • Haemonetics Corp

    00%

  • DENTSPLY SIRONA Inc

    00%

  • Cooper Companies Inc

    00%

  • Neogen Corp

    00%

  • ICU Medical Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    18587.6

  • Ticker

    COO.OQ

  • ISIN

    US2166485019

  • IPO date

    1983-01-21

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-03-01

  • Date fact. publication of reports

    2024-01-31

Company Description

The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.